SHELL ASSET MANAGEMENT CO - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 3 filers reported holding LEGEND BIOTECH CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$81
-2.4%
1,2000.0%0.00%0.0%
Q2 2023$83
-66.3%
1,200
-76.5%
0.00%
-70.0%
Q1 2023$246
-3.5%
5,1000.0%0.01%
-9.1%
Q4 2022$255
-99.8%
5,100
+70.0%
0.01%
+120.0%
Q3 2022$122,000
-70.8%
3,000
-60.5%
0.01%
-58.3%
Q2 2022$418,0007,6000.01%
Other shareholders
LEGEND BIOTECH CORP shareholders Q4 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 1,629,173$89,605,00022.89%
Paradigm Biocapital Advisors LP 978,596$53,823,00010.73%
FengHe Fund Management Pte. Ltd. 475,263$26,139,00010.25%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,222,342$67,229,0009.65%
HHLR ADVISORS, LTD. 4,436,617$244,014,0005.23%
Iron Triangle Partners LP 495,329$27,243,0003.53%
Parkman Healthcare Partners LLC 117,807$6,479,0002.39%
AtonRa Partners 28,172$1,549,0001.42%
Vivo Capital, LLC 244,375$13,441,0001.35%
Avidity Partners Management LP 1,000,000$55,000,0001.26%
View complete list of LEGEND BIOTECH CORP shareholders